- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Koracevic G, Stojanovic M, Petrovic S, Simic D, Sakac D, Vlajkovic M, Stevic M, Kocic M, Dordevic M, Koracevic M
Cushing’s Syndrome, a Risk Factor for Venous Thromboembolism is a Candidate for Guidelines
Acta Endo (Buc) 2020, 16 (2): 123-128doi: 10.4183/aeb.2020.123
Objectives. The present paper aims to review
important contemporary information about VTE risk in
endogenous and exogenous CS, as a substantial discrepancy
exists between the results of a recent meta-analysis
confirming the increased risk for VTE and the absence of CS
in VTE guidelines.
Methods. An extensive search of relevant
databases (e.g. PubMed, Google Scholar, and Scopus)
was performed in order to establish the interconnectedness
of the following terms: Cushing’s syndrome, venous
thromboembolism, deep vein thrombosis, pulmonary
embolism.
Results. The analysis demonstrated that patients
with CS have about ten times the risk for VTE, particularly
during the first year following the diagnosis of CS. Oral
glucocorticoid users (with iatrogenic CS) have a 3-fold
increase in risk of VTE in comparison with non-users.
The most recent 2019 meta-analysis encompassed 7142
patients with endogenous CS (including Cushing’s disease)
undergoing transsphenoidal surgery or adrenalectomy, and
their risk of unprovoked VTE was almost 18 times higher in
comparison with a healthy population.
Conclusion. Over the past 50 years considerable
evidence of increased VTE risk in CS has been accumulated.
It pertains to both endogenous and exogenous type of CS
and has been confirmed in the vast majority, if not all the
available studies, including meta-analyses. Nevertheless,
official CS guidelines make no mention of CS as a VTE risk
factor, even though it is important that not only physicians
who treat CS, but also physicians who manage patients with
suspected VTE be aware of increased VTE risk.
Keywords: Cushing’s syndrome, venous thromboembolism, deep vein thrombosis, pulmonary embolism, guidelines.
Correspondence: Milan Ðordevic MD, Health Centre Jagodina, Emergency Medical Service, Vojvode Tankosica 2. prilaz, Broj 17,
Niš-Medijana, Niš, 18000, Serbia, E-mail: milan_mdj@hotmail.com